Investing.com - Financial Markets Worldwide

AstraZeneca CFO Aradhana Sarin sells 9,563 shares in London transaction

Published 18/08/2025, 16:14
© Reuters
AZN
1.57%

AstraZeneca PLC (LON:AZN, NASDAQ:AZN) reported Monday that Executive Director and Chief Financial Officer Aradhana Sarin sold 9,563 ordinary shares of the company on Thursday, August 14. The transaction was carried out on the London Stock Exchange (LON:LSEG) at a price of £115.117 per share.

The company disclosed the transaction in a statement based on regulatory requirements for reporting share dealings by persons discharging managerial responsibilities. The notification was made to AstraZeneca (NASDAQ:AZN) on August 15.

According to the filing, the shares sold were ordinary shares of $0.25 each, identified under the code GB0009895292. The notification is an initial disclosure and was made in accordance with the EU Market Abuse Regulation as it applies in UK law.

This information is based on a press release statement included in a regulatory filing with the U.S. Securities and Exchange Commission.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.